14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
OHI vs SBRA: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
OHI Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 7–3 Matrix Metrics)
OHI Overall Winner
6-Pillar Tally: OHI 4 – 2 SBRA
Matrix Metrics: OHI 7 – 3 SBRA
As of Nov 16, 2026, Omega Healthcare Investors Inc. (OHI) is the stronger overall head-to-head candidate over Sabra Healthcare REIT, Inc. (SBRA) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). OHI carries a Unified Composite Score of 50.5/100 (HOLD) at $46.91 (22.6x Forward P/E, 62.6% operating margin), whereas SBRA carries 54.9/100 (HOLD) at $20.42 (28.2x Forward P/E, 18.4% operating margin).
Composite vs. Pillar Nuance: While SBRA currently prints a higher short-term Unified Composite Score (54.9/100 HOLD vs. OHI 50.5/100 HOLD), OHI captures the overall institutional head-to-head verdict (7–3 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (62.6% vs. 18.4% operating margin) and revenue trajectory (-0.6% vs. +31.6% YoY).
Technical & Structure Timing Caution: OHI is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.6); meanwhile SBRA trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 54.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Competes within the REIT - Healthcare Facilities value chain with $5.4B market capitalization and 18.4% operating margin.
OpEx & R&D Reinvestment31.2% of Rev ($288M)
90D Engineering Disclosures0 Published
Investor FAQ OHI vs SBRA Key Questions & Quantitative Answers
As of Nov 16, 2026, Omega Healthcare Investors Inc. (OHI) is the stronger overall head-to-head candidate over Sabra Healthcare REIT, Inc. (SBRA) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). OHI carries a Unified Composite Score of 50.5/100 (HOLD) at $46.91 (22.6x Forward P/E, 62.6% operating margin), whereas SBRA carries 54.9/100 (HOLD) at $20.42 (28.2x Forward P/E, 18.4% operating margin). Composite vs. Pillar Nuance: While SBRA currently prints a higher short-term Unified Composite Score (54.9/100 HOLD vs. OHI 50.5/100 HOLD), OHI captures the overall institutional head-to-head verdict (7–3 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (62.6% vs. 18.4% operating margin) and revenue trajectory (-0.6% vs. +31.6% YoY). Technical & Structure Timing Caution: OHI is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.6); meanwhile SBRA trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 54.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
SBRA leads the Growth & Scale pillar: OHI posts -0.6% YoY revenue growth and -55.4% YoY earnings growth on $1.26B TTM revenue (95.8% gross margin, 62.6% operating margin), compared with SBRA at +31.6% YoY revenue growth and +22.2% YoY earnings growth on $924M TTM revenue (49.6% gross margin, 18.4% operating margin). Across the 5-period historical trajectory (Q3 '25 to Q3 '26), OHI cumulative revenue shifted +8.8% while SBRA shifted +31.6%. In operating R&D and SG&A reinvestment, OHI deploys 33.2% of Rev ($418M) (0 90-day corporate R&D disclosures) versus 31.2% of Rev ($288M) (0 disclosures) for SBRA.
OHI screens cheaper on headline valuation multiples. OHI trades at 22.6x Forward P/E, 19.0x Trailing P/E, 11.99x PEG, and 14.9x EV/Revenue (67.9% FCF margin), whereas SBRA trades at 28.2x Forward P/E, 76.2x Trailing P/E, 5.28x PEG, and 8.4x EV/Revenue (43.3% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against OHI (14.5% ROE) versus SBRA (2.5% ROE) capital efficiency.
In options market volatility and institutional positioning, OHI carries 26.9% implied volatility (65th %ile, Elevated (60th–80th %ile)), a 0.71x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.04β · 29% Vol realized risk). By comparison, SBRA carries 21.6% implied volatility (6th %ile, Compressed (<25th %ile)), a 0.11x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.01β · 31% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.